These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

711 related items for PubMed ID: 19429297

  • 1. Diclofenac nanosuspensions: influence of preparation procedure and crystal form on drug dissolution behaviour.
    Lai F, Sinico C, Ennas G, Marongiu F, Marongiu G, Fadda AM.
    Int J Pharm; 2009 May 21; 373(1-2):124-32. PubMed ID: 19429297
    [Abstract] [Full Text] [Related]

  • 2. Enhancement of dissolution rate and bioavailability of aceclofenac: a chitosan-based solvent change approach.
    Mutalik S, Anju P, Manoj K, Usha AN.
    Int J Pharm; 2008 Feb 28; 350(1-2):279-90. PubMed ID: 17945447
    [Abstract] [Full Text] [Related]

  • 3. Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.
    Liu P, Rong X, Laru J, van Veen B, Kiesvaara J, Hirvonen J, Laaksonen T, Peltonen L.
    Int J Pharm; 2011 Jun 15; 411(1-2):215-22. PubMed ID: 21458552
    [Abstract] [Full Text] [Related]

  • 4. Preparation and characterization of freeze-dried 2-methoxyestradiol nanoparticle powders.
    Du B, Li XT, Zhao Y, A YM, Zhang ZZ.
    Pharmazie; 2010 Jul 15; 65(7):471-6. PubMed ID: 20662313
    [Abstract] [Full Text] [Related]

  • 5. Nanocrystals as tool to improve piroxicam dissolution rate in novel orally disintegrating tablets.
    Lai F, Pini E, Angioni G, Manca ML, Perricci J, Sinico C, Fadda AM.
    Eur J Pharm Biopharm; 2011 Nov 15; 79(3):552-8. PubMed ID: 21820052
    [Abstract] [Full Text] [Related]

  • 6. Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs.
    Kocbek P, Baumgartner S, Kristl J.
    Int J Pharm; 2006 Apr 07; 312(1-2):179-86. PubMed ID: 16469459
    [Abstract] [Full Text] [Related]

  • 7. In vitro and in vivo evaluation of silybin nanosuspensions for oral and intravenous delivery.
    Wang Y, Zhang D, Liu Z, Liu G, Duan C, Jia L, Feng F, Zhang X, Shi Y, Zhang Q.
    Nanotechnology; 2010 Apr 16; 21(15):155104. PubMed ID: 20332565
    [Abstract] [Full Text] [Related]

  • 8. Novel nanosized formulations of two diclofenac acid polymorphs to improve topical bioavailability.
    Pireddu R, Sinico C, Ennas G, Marongiu F, Muzzalupo R, Lai F, Fadda AM.
    Eur J Pharm Sci; 2015 Sep 18; 77():208-15. PubMed ID: 26116276
    [Abstract] [Full Text] [Related]

  • 9. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
    Zahedi P, Lee PI.
    Eur J Pharm Biopharm; 2007 Mar 18; 65(3):320-8. PubMed ID: 17182231
    [Abstract] [Full Text] [Related]

  • 10. Hydrate modifications of the non-steroidal anti-inflammatory drug diclofenac sodium: Solid-state characterisation of a trihydrate form.
    Bartolomei M, Rodomonte A, Antoniella E, Minelli G, Bertocchi P.
    J Pharm Biomed Anal; 2007 Nov 05; 45(3):443-9. PubMed ID: 17709225
    [Abstract] [Full Text] [Related]

  • 11. Improved bioavailability of aceclofenac from spherical agglomerates: development, in vitro and preclinical studies.
    Muatlik S, Usha AN, Reddy MS, Ranjith AK, Pandey S.
    Pak J Pharm Sci; 2007 Jul 05; 20(3):218-26. PubMed ID: 17545107
    [Abstract] [Full Text] [Related]

  • 12. Development and physicochemical evaluation of pharmacosomes of diclofenac.
    Semalty A, Semalty M, Singh D, Rawat MS.
    Acta Pharm; 2009 Sep 05; 59(3):335-44. PubMed ID: 19819829
    [Abstract] [Full Text] [Related]

  • 13. Preparation and characterization of nanocrystals for solubility and dissolution rate enhancement of nifedipine.
    Hecq J, Deleers M, Fanara D, Vranckx H, Amighi K.
    Int J Pharm; 2005 Aug 11; 299(1-2):167-77. PubMed ID: 15996838
    [Abstract] [Full Text] [Related]

  • 14. Preparation of stable nitrendipine nanosuspensions using the precipitation-ultrasonication method for enhancement of dissolution and oral bioavailability.
    Xia D, Quan P, Piao H, Piao H, Sun S, Yin Y, Cui F.
    Eur J Pharm Sci; 2010 Jul 11; 40(4):325-34. PubMed ID: 20417274
    [Abstract] [Full Text] [Related]

  • 15. Enhanced dissolution and oral bioavailability of aripiprazole nanosuspensions prepared by nanoprecipitation/homogenization based on acid-base neutralization.
    Xu Y, Liu X, Lian R, Zheng S, Yin Z, Lu Y, Wu W.
    Int J Pharm; 2012 Nov 15; 438(1-2):287-95. PubMed ID: 22989976
    [Abstract] [Full Text] [Related]

  • 16. Solution calorimetry as an alternative approach for dissolution testing of nanosuspensions.
    Kayaert P, Li B, Jimidar I, Rombaut P, Ahssini F, Van den Mooter G.
    Eur J Pharm Biopharm; 2010 Nov 15; 76(3):507-13. PubMed ID: 20887787
    [Abstract] [Full Text] [Related]

  • 17. Effects of stabilizing agents on the development of myricetin nanosuspension and its characterization: an in vitro and in vivo evaluation.
    Hong C, Dang Y, Lin G, Yao Y, Li G, Ji G, Shen H, Xie Y.
    Int J Pharm; 2014 Dec 30; 477(1-2):251-60. PubMed ID: 25445518
    [Abstract] [Full Text] [Related]

  • 18. Comminution of ibuprofen to produce nano-particles for rapid dissolution.
    Plakkot S, de Matas M, York P, Saunders M, Sulaiman B.
    Int J Pharm; 2011 Aug 30; 415(1-2):307-14. PubMed ID: 21683776
    [Abstract] [Full Text] [Related]

  • 19. Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
    Lai F, Pini E, Corrias F, Perricci J, Manconi M, Fadda AM, Sinico C.
    Int J Pharm; 2014 Jun 05; 467(1-2):27-33. PubMed ID: 24680963
    [Abstract] [Full Text] [Related]

  • 20. Preparation and, in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates.
    Usha AN, Mutalik S, Reddy MS, Ranjith AK, Kushtagi P, Udupa N.
    Eur J Pharm Biopharm; 2008 Oct 05; 70(2):674-83. PubMed ID: 18606224
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.